ClinicalTrials.gg
Sign In

Jaundice, Neonatal clinical trials

The registry lists 110 studies for Jaundice, Neonatal across more than 10 countries. 28 are recruiting or about to start. 89 of them are mainly about Jaundice, Neonatal (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-30.

Get an email when these change. Save the Jaundice, Neonatal studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
58
Status unknown
15
Not yet recruiting
14
Recruiting
13
Active, not recruiting
3
Terminated
3

Phase

Phase 2
7
Phase 3
5
Phase 4
2
Phase 1
2

Where

United States
17
Turkey
17
Pakistan
4
Norway
4
China
4
Canada
4

Who runs them

Picterus AS (11) · University of Minnesota (4) · Norwegian University of Science and Technology (3) · Assiut University (3) · InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (3) · Ege University (2) · St. Olavs Hospital (2) · Mansoura University (2)

What is being tested here

Drugs under test in Jaundice, Neonatal studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bifidobacterium animalis subsp. lactis303
Fenofibrate214
Streptococcus thermophilus101
Bifidobacterium breve101
Lacteol101
Lactobacillus plantarum101
Lacticaseibacillus paracasei101
Lactobacillus helveticus101
Tin mesoporphyrin012
Vitamin D001

Coming up

2phase 3 studies under way
8studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8, phase 3 first

Who these studies take

Of the 13 Jaundice, Neonatal studies recruiting now, 1 (8%) set no upper age limit and 12 (92%) stop at 75 or younger. 11 (85%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 8 (62%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
100 (0%)0 (0%)
182 (15%)1 (8%)
302 (15%)1 (8%)
402 (15%)1 (8%)
501 (8%)1 (8%)
651 (8%)1 (8%)
751 (8%)1 (8%)
851 (8%)1 (8%)

Across all 110 studies, recruiting or not: 89% stop at 75 or younger and 89% at 65; 91% take children; 11% are for women only and 0% for men only; 45% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Jaundice, Neonatal studies take

Of 45 interventional studies with no phase under Jaundice, Neonatal, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase11 mo5–21 · 45 studies—12 mo5–21 · 35 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 110. Browse all 110 → or search them.